Prospective study observes obesity and comorbidities influencing COVID-19 pneumonia severity in hospitalized patients, highlighting biomarkers associated with mortality risk.
The studies of the clinical and demographic characteristics of COVID-19 patients around the world have made it possible to observe a rich semiology, which implicated obesity as a factor in the severity of COVID-19 pneumonia, and can lead to intensive care or even death. Some biomarkers have been identified as risk factors for mortality. The aim of this study is to verify obesity and the risk factors for mortality of COVID-19 infection.
No takes yet. Share an insight, caveat, or question.
Ketfi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: